There has been controversy concerning the need to treat patients with a hypersensitive carotid sinus reflex since this was first recognised as a cause of syncope in man.' There is, however, evidence that syncopal patients with a hypersensitive carotid sinus reflex will continue to suffer disabling symptoms unless treated. 2 Pacing is now accepted as the treatment of first choice for syncopal patients with a pure or predominant cardioinhibitory response to carotid sinus massage. 2 24 November 1981 ported2 13 14 and has been attributed to the vasodepressor response. 13 15 Hypotension occurring with the onset of ventricular pacing (pacemaker effect) has not been previously reported as a cause of persistent symptoms, either alone, or in combination with the vasodepressor response in paced carotid sinus syndrome patients. This paper presents a sufficiently large series of patients paced for carotid sinus syndrome to allow analysis of persistent symptoms.
Patients and methods
Seventy patients with a primary diagnosis of carotid sinus syndrome were paced over a four year period. 18 
Results
The initial and final pacing modes and the incidence of persistent symptoms in the 70 patients with carotid sinus syndrome are shown in Table 2 .
Complete relief of symptoms before unit change was achieved in 77% of patients (85% of patients with VVI pacing, all patients with DVI/DDD pacing, and none of the eight patients with atrial pacing). After conversion of pacing symptoms (see Table 2 ), complete relief of symptoms was achieved in 89% of patients. There have been only four deaths: three in the asymptomatic group (two deaths from carcinoma and one from cerebrovascular accident) and one death in the group with persistent symptoms which was sudden and unexplained. PERSISTENT 
SYMPTOMS
Initially 16 patients had persistent symptoms. Eight of these patients had atrial (AAI) pacemakers, and eight had ventricular (VVI) pacemakers. All eight atrially paced patients had symptomatic atrioventricular block during carotid sinus massage (Fig. 4) . Their symptoms were therefore attributed to lack of adequate control of bradycardia, and these patients were electively converted to either a ventricular or dual chamber pacing system (VVI or DVI/DDD).
Four of these patients are now asymptomatic with DVI or DDD pacemakers, but four had persistent symptoms despite conversion to VVI (two patients), DVI (one patient), and DDD (one patient). Thus 12 patients were left with persistent symptoms despite adequate control of bradycardia (10 VVI, one DVI, one DDD).
The results of the arterial pressure studies in these 12 patients, the asymptomatic carotid sinus syndrome group, and the group without carotid sinus syndrome are shown in Table 3 and Fig. 5 depressor response and pacemaker effect was greatest in the group with persistent symptoms (group 1) p<0-01. The isolated pacemaker effect was also greatest in this group, p<0-05. No significant hypotension was demonstrated with the onset of atrioventricular sequential pacing. Table 4 shows that the three groups were comparable for age, incidence of ischaemic heart disease, and hypertension. Women predominated in the group without carotid sinus syndrome and evidence of sinoatrial disease was more common in patients with the carotid sinus syndrome.
Discussion
There has been an unexpectedly high incidence of carotid sinus syndrome. The criteria used for diagnosing carotid sinus syndrome were stringent. Only patients with disabling symptoms or definite syncope were paced. Hypersensitive carotid sinus reflex was diagnosed at the bedside and subsequently confirmed at electrophysiological study, which allowed assessment of other cardiac conduction defects and confirmation that symptoms precipitated by carotid Scalar ECG leads L [I. III CSM on sinus massage could be abolished by temporary pacing (Fig. 1 ). There was a high incidence (55%) of electrophysiological evidence of sinoatrial disease (either prolonged sinus node recovery time or paroxysmal atrial fibrillation precipitated by atrial pacing). This association has been noted by others.'9 None of the patients had overt sick sinus syndrome on resting or 24 hour electrocardiogram. All patients were therefore considered to have a primary diagnosis of carotid sinus syndrome.
Eight patients early in this series were selected for atrial pacing on the grounds of haemodynamic benefit of atrial pacing shown at catheterisation (cardiac output and mean aortic pressure recordings) and control of bradycardia without atrioventricular block at electrophysiological study. Atrial pacing, however, is clearly contraindicated in view of the appearance of recurrent symptoms in all atrially paced patients with carotid sinus syndrome and the demonstration of symptomatic atrioventricular block with carotid sinus massage at follow up.
Four of the atrially paced patients continued to have symptoms after pacemaker conversion, two to VVI, one to DVI and one to DDD pacing. Of these four patients, the two with VVI pacing were shown to have a combination of vasodepressor response plus pacemaker effect sufficient to explain their symptoms and the DVI and DDD patients both had severe vasodepressor responses.
Ventricular demand (WI) pacing was successful in 85% of patients who were initially selected for VVI pacing. These group.bmj.com on October 14, 2017 -Published by http://heart.bmj.com/ Downloaded from ences of atrioventricular dissociation but that there may be an atrial stretch reflex in man (as shown in cats25) which is activated by the high atrial pressures. These occur when the atria contract against closed atrioventricular valves. The response to this reflex might be expected to be greater in patients with a vasodepressor response to carotid sinus massage as presumably they have a hypersensitive vasomotor centre.
Atrioventricular pacing has been shown to abolish the pacemaker effect and is therefore likely to be helpful in the persistent symptoms group. Four of the patients with ventricular pacemakers have been converted to DVI pacing with improvement, but follow up is too short to make further comment. The remaining six symptomatic VVI paced patients have been considered for conversion to DVI pacing. One patient is excluded because of chronic atrial fibrillation, one patient has refused conversion, and four patients have only mild or infrequent symptoms and are being followed up closely.
Four patients (two VVI, one DVI, one DDD) were shown to have a vasodepressor response sufficient to cause symptoms without additional pacemaker effect and at present there is no satisfactory treatment for these patients, but DVI pacing may, however, reduce the severity of their symptoms by eliminating the carotid sinus cardioinhibitory response and pacemaker effect. Arterial pressure study before pacing patients with carotid sinus syndrome is helpful in selecting the most appropriate mode of pacing. Patients with a vasodepressor response or combinations of vasodepressor response plus pacemaker effect sufficient to reproduce symptoms, in addition to cardioinhibitory response, should be selected for DVI pacing.
In this series 890/o of patients have been rendered asymptomatic with appropriate choice of pacing system. Forty-eight patients (68%) are asymptomatic with VVI pacing, and 14 with DVI/DDD pacing. A further four patients symptomatic with VVI pacing would almost certainly benefit from conversion to DVI pacing which is therefore considered the most appropriate mode of pacing in 18 patients (26%). Only four patients (6%) are likely to remain symptomatic, regardless of pacing mode, in view of severe vasodepressor response.
The hypersensitive carotid sinus syndrome is thus more common than previously recognised and cardiac pacing is a highly effective treatment provided the correct mode is selected.
